SCRUTINIZING THE BIOMARKERS FOR THE NEGLECTED CHAGAS DISEASE: HOW REMARKABLE!
Biomarkers or biosignature profiles have become accessible over time in population-based studies for Chagas disease. Thus, the identification of consistent and reliable indicators of the diagnosis and prognosis of patients with heart failure might facilitate the prioritization of therapeutic managem...
Main Authors: | Rosa Pinho, Mariana Waghabi, Fabíola Cardillo, José Mengel, PAULO ANTAS |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00306/full |
Similar Items
-
CHRONIC CHAGAS’ DISEASE: TARGETING THE INTERLEUKIN-2 AXIS AND REGULATORY T CELLS IN A CONDITION FOR WHICH THERE IS NO TREATMENT
by: Jose eMengel, et al.
Published: (2016-05-01) -
Indeterminate form of Chagas disease
by: Macêdo Vanize
Published: (1999-01-01) -
Clinical treatment of the digestive form of Chagas disease
by: Ulysses G Meneghelli
Published: (1999-09-01) -
Esophageal manometry and vectorcardiography study of asymptomatic patients with Chagas' disease
by: Joaquim Prado P. Moraes-Filho, et al.
Published: (1988-12-01) -
Experimental Chagas' disease in dogs
by: Marta de Lana, et al.
Published: (1992-03-01)